Literature DB >> 11934230

Pharmaceutical evaluation of gas-filled microparticles as gene delivery system.

Stefanie Seemann1, Peter Hauff, Marcus Schultze-Mosgau, Cathleen Lehmann, Regina Reszka.   

Abstract

PURPOSE: To produce and characterize a nonviral ultrasound-controlled release system of plasmid DNA (pDNA) encapsulated in gas-filled poly(D,L-lactide-co-glycolide) microparticles (PLGA-MPs).
METHODS: Different cationic polymers were used to form pDNA/polymer complexes to enhance the stability of pDNA during microparticle preparation. The physico-acoustical properties of the microparticles, particle size, pDNA integrity, encapsulation efficiency and pDNA release behavior were studied in vitro.
RESULTS: The microparticles had an average particle size of around 5 microm. More than 50% of all microparticles contained a gas core, and when exposed to pulsed ultrasound as used for color Doppler imaging create a signal that yields typical color patterns (stimulated acoustic emission) as a result of the ultrasound-induced destruction of the microparticles. Thirty percent of the pDNA used was successfully encapsulated and approximately 10% of the encapsulated pDNA was released by ultrasound within 10 min.
CONCLUSIONS: Plasmid DNA can be encapsulated in biodegradable gas-filled PLGA-MPs without hints for a structural disintegration. A pDNA release by ultrasound-induced microparticle-destruction could be shown in vitro.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934230     DOI: 10.1023/a:1014430631844

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

1.  Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics.

Authors:  E Walter; K Moelling; J Pavlovic; H P Merkle
Journal:  J Control Release       Date:  1999-09-20       Impact factor: 9.776

Review 2.  Retroviral vectors.

Authors:  K M Kurian; C J Watson; A H Wyllie
Journal:  Mol Pathol       Date:  2000-08

3.  Gene transfer in vitro and in vivo by cationic lipids is not significantly affected by levels of supercoiling of a reporter plasmid.

Authors:  D Bergan; T Galbraith; D L Sloane
Journal:  Pharm Res       Date:  2000-08       Impact factor: 4.200

4.  Preparation and characterization of poly (D,L-lactide-co-glycolide) microspheres for controlled release of poly(L-lysine) complexed plasmid DNA.

Authors:  Y Capan; B H Woo; S Gebrekidan; S Ahmed; P P DeLuca
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

5.  Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue.

Authors:  D M Skyba; R J Price; A Z Linka; T C Skalak; S Kaul
Journal:  Circulation       Date:  1998-07-28       Impact factor: 29.690

6.  Stability of peptide-condensed plasmid DNA formulations.

Authors:  R C Adami; W T Collard; S A Gupta; K Y Kwok; J Bonadio; K G Rice
Journal:  J Pharm Sci       Date:  1998-06       Impact factor: 3.534

7.  Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission.

Authors:  P Hauff; T Fritzsch; M Reinhardt; W Weitschies; F Lüders; V Uhlendorf; D Heldmann
Journal:  Invest Radiol       Date:  1997-02       Impact factor: 6.016

8.  Transfection of a reporter plasmid into cultured cells by sonoporation in vitro.

Authors:  S Bao; B D Thrall; D L Miller
Journal:  Ultrasound Med Biol       Date:  1997       Impact factor: 2.998

9.  Cationic phosphonolipids as nonviral vectors: in vitro and in vivo applications.

Authors:  P Delépine; C Guillaume; V Floch; S Loisel; J Yaouanc; J Clément; H Des Abbayes; C Férec
Journal:  J Pharm Sci       Date:  2000-05       Impact factor: 3.534

10.  High-frequency ultrasonic absorption spectroscopy on aqueous suspensions of phospholipid bilayer vesicles.

Authors:  U Kaatze; K Lautscham
Journal:  Biophys Chem       Date:  1988-12       Impact factor: 2.352

View more
  7 in total

1.  Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors.

Authors:  Shashank R Sirsi; Sonia L Hernandez; Lukasz Zielinski; Henning Blomback; Adel Koubaa; Milo Synder; Shunichi Homma; Jessica J Kandel; Darrell J Yamashiro; Mark A Borden
Journal:  J Control Release       Date:  2011-09-17       Impact factor: 9.776

Review 2.  [Possible target specific molecular imaging with ultrasound contrast agents].

Authors:  M Mäurer; R Linker; M Reinhardt; P Hauff
Journal:  Radiologe       Date:  2005-06       Impact factor: 0.635

3.  Microbubble Compositions, Properties and Biomedical Applications.

Authors:  Shashank Sirsi; Mark Borden
Journal:  Bubble Sci Eng Technol       Date:  2009-11

4.  Plasma sterilization of poly lactic acid ultrasound contrast agents: surface modification and implications for drug delivery.

Authors:  John R Eisenbrey; Jennifer Hsu; Margaret A Wheatley
Journal:  Ultrasound Med Biol       Date:  2009-09-19       Impact factor: 2.998

Review 5.  Current status and prospects for microbubbles in ultrasound theranostics.

Authors:  K Heath Martin; Paul A Dayton
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-03-15

Review 6.  Cell and tissue targeting of nucleic acids for cancer gene therapy.

Authors:  Verena Russ; Ernst Wagner
Journal:  Pharm Res       Date:  2007-03-27       Impact factor: 4.580

Review 7.  Advances in ultrasound mediated gene therapy using microbubble contrast agents.

Authors:  Shashank R Sirsi; Mark A Borden
Journal:  Theranostics       Date:  2012-12-31       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.